An in vivo model for measuring antigen‐induced SRS‐A‐mediated bronchoconstriction and plasma S RS‐ A levels in the guinea‐pig
Authors:
Open Access
- 1 January 1983
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 78 (1) , 67-74
Abstract
Pharmacological modulation of antigen‐induced anaphylaxis in actively sensitized guinea‐pigs with intravenously administered indomethacin (10 mg/kg), pyrilamine (2.0 mg/kg) and propranolol (0.1 mg/kg) resulted in a delayed onset, slowly developing bronchoconstriction indicative of a slow‐reacting substance of anaphylaxis (SRS‐A) response. Measurements of pulmonary mechanics on the drug‐pretreated animals challenged with ovalbumin demonstrated a more prominent effect on dynamic compliance than resistance. This is consistent with the more potent effects of SRS‐A on peripheral rather than central airways. The slowly developing bronchoconstriction obtained after treatment with indomethacin, pyrilamine and propranolol was inhibited by the standard SRS‐A antagonist, FPL 55712 and the SRS‐A synthesis inhibitors, phenidone, BW 755C and nordihydroguaiaretic acid. Plasma SRS‐A levels were determined in guinea‐pigs following antigen challenge. The appearance of SRS‐A in the plasma preceded the onset of bronchoconstriction and SRS‐A levels remained elevated throughout its development. Coincident with the inhibition of bronchoconstriction by the SRS‐A synthesis inhibitor, phenidone, was a dose‐dependent reduction in plasma SRS‐A. The intravenous ED50 in each case was 4 mg/kg. This model of antigen‐induced SRS‐A‐mediated bronchoconstriction should prove useful for the in vivo evaluation and development of therapeutics which regulate the synthesis of SRS‐A.Keywords
This publication has 40 references indexed in Scilit:
- Release of slow-reacting substance of anaphylaxis from dispersed pig lung cells: effect of cyclo-oxygenase and lipoxygenase inhibitorsJournal of Allergy and Clinical Immunology, 1981
- SRSA-mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivoInflammation Research, 1981
- From slow reacting substance of anaphylaxis (SRS-A) to leukotriene D4 (LTD4)International Journal of Immunopharmacology, 1980
- Formation of the cysteinyl form of slow reacting substance (leukotriene E4) in human plasmaBiochemical and Biophysical Research Communications, 1980
- Mediators of Immediate Hypersensitivity Derived from Arachidonic AcidNew England Journal of Medicine, 1980
- Inhibition of the release of slow-reacting substance of anaphylaxis by inhibitors of lipoxygenase activityJournal of Pharmacy and Pharmacology, 1980
- Total synthesis of (5S,6R,7E,9E,11Z,14Z)-5-hydroxy-6-[(2R)-2-amino-2-(carboxyethyl)thio]-7,9,11,14-eicosatetraenoic acid, a potent SRS-AJournal of the American Chemical Society, 1980
- FPL 55712 — An antagonist of slow reacting substance of anaphylaxis (SRS-A): A reviewInflammation Research, 1979
- Effects of Intravenous Administration of Slow-Reacting Substance of Anaphylaxis, Histamine, Bradykinin, and Prostaglandin F2α on Pulmonary Mechanics in the Guinea PigJournal of Clinical Investigation, 1974
- The mechanical properties of the lungs in experimental asthma in the guinea pigJournal of Allergy, 1961